Presentation TCT 2016 What are Valid Absolute and Relative Contraindications to Warfarin and NOACs? Presenter: Freek W.A. Verheugt October 30, 2016 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2016 Left Atrial Appendage Up Next Presentation TCT 2016 Featured Lecture: Interventional Innovation is Alive and Well Reflections and Predictions Presenter: Elazer R. Edelman October 30, 2016 More slides + Presentation TCT 2016 Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation Presenter: Vivek Y. Reddy October 30, 2016 Presentation TCT 2016 Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness) Presenter: Vivek Y. Reddy October 30, 2016 We Recommend
Presentation TCT 2016 Featured Lecture: Interventional Innovation is Alive and Well Reflections and Predictions Presenter: Elazer R. Edelman October 30, 2016
Presentation TCT 2016 Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation Presenter: Vivek Y. Reddy October 30, 2016
Presentation TCT 2016 Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness) Presenter: Vivek Y. Reddy October 30, 2016